Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Cilostazol on Cognitive Decline in High-risk Elderly People with Ischemic Stroke Compared to Aspirin or Clopidogrel
KCT0007807Phase 4Not yet recruiting
- Sponsor
- Korea Otsuka Pharmaceutical
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in ischemic stroke, Dementia, confusion, sponsored by Korea Otsuka Pharmaceutical. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
cilostazol
03
Conditions
ischemic strokeDementiaconfusion
Beyond the preview
Go deeper on KCT0007807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007807.